Transoral incisionless fundoplication (TIF) was shown to be more effective than taking the maximal proton pump inhibitor (PPI) dose in relieving heartburn, regurgitation, and other troublesome symptoms in patients with refractory gastroesophageal reflux disease (GERD).
Esophageal pH monitoring is more cost effective than the long-term use of proton-pump inhibitors (PPIs), since it can help rule out gastroesophageal reflux diseases (GERD) and avoid the unneeded costs associated with prolonged medication therapy.
Labeling an infant's spitting up as gastroesophageal reflux disease (GERD) makes parents more interested in utilizing medication even when they are told the treatment is likely to be ineffective, according to a study published online April 1 in Pediatrics.
In patients with gastroesophageal reflux disease and a partial response to proton-pump inhibitors, a device to augment the lower esophageal sphincter improves reflux symptoms, reduces use of proton-pump inhibitors, and improves quality of life, according to a study published in the Feb. 21 issue of the New England Journal of Medicine.
Proton pump inhibitors (PPI) are effective in many patients with gastroesophageal reflux disease (GERD), but up to half of patients do not experience symptom relief with these medications.
